{"id":"minoxidil-lotion-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Scalp irritation"},{"rate":null,"effect":"Dryness"},{"rate":null,"effect":"Itching"},{"rate":null,"effect":"Unwanted facial hair growth"},{"rate":null,"effect":"Contact dermatitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Minoxidil works by dilating blood vessels in the scalp, improving nutrient and oxygen delivery to hair follicles. It also directly stimulates hair follicle growth and extends the active growth phase, shifting hairs from telogen (resting) to anagen (growth) phase. The exact molecular mechanism remains incompletely understood, but vasodilation and direct follicle stimulation are the primary proposed mechanisms.","oneSentence":"Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:38:38.490Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Androgenetic alopecia (male and female pattern hair loss)"}]},"trialDetails":[{"nctId":"NCT04594018","phase":"PHASE3","title":"Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia","status":"RECRUITING","sponsor":"EMS","startDate":"2023-02-02","conditions":"Androgenetic Alopecia","enrollment":190},{"nctId":"NCT04209803","phase":"PHASE4","title":"N-Acetyl-Cysteine for Treatment of AGA in Men","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2018-12-01","conditions":"Androgenetic Alopecia","enrollment":100},{"nctId":"NCT00175617","phase":"PHASE2","title":"Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2005-09","conditions":"Female Pattern Hair Loss","enrollment":40},{"nctId":"NCT01924000","phase":"PHASE4","title":"Minoxidil 1% for Eyebrow Enhancement","status":"COMPLETED","sponsor":"Mae Fah Luang University Hospital","startDate":"2013-12","conditions":"Eyebrow Hypotrichosis, Thin Eyebrow","enrollment":40},{"nctId":"NCT01672307","phase":"PHASE4","title":"Minoxidil 2% for Eyebrow Enhancement","status":"COMPLETED","sponsor":"Mae Fah Luang University Hospital","startDate":"2012-09","conditions":"Hypotrichosis of Eyebrows, Thinning Eyebrows","enrollment":40},{"nctId":"NCT01391156","phase":"PHASE3","title":"Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss","status":"COMPLETED","sponsor":"Mae Fah Luang University Hospital","startDate":"2011-03","conditions":"Androgenetic Alopecia","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Minoxidil lotion 1%","genericName":"Minoxidil lotion 1%","companyName":"Mae Fah Luang University Hospital","companyId":"mae-fah-luang-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Minoxidil lotion 1% is used to treat conditions such as Eyebrow Hypotrichosis, Thin Eyebrow, Female Pattern Hair Loss, and Androgenetic Alopecia, as indicated by ClinicalTrials.gov. The mechanism of action of Minoxidil 1% is not explicitly stated in the provided facts, but it is listed as an intervention in various studies, suggesting its use in treating these conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}